USPTO Grants Apotex's Bid To Review Plavix Patent
The U.S. Patent and Trademark Office has granted generic-drug maker Apotex Corp.'s request for re-examination of Sanofi-Aventis' patent for blood-thinner Plavix, as Apotex fights to break down intellectual property barriers to...To view the full article, register now.
Already a subscriber? Click here to view full article